Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

MedComm

Showing results (411-420 of 1,530) with videos related to

Pageof 153
Sort By:
Medcomm|March 6, 2025
Metabolic reprogramming in cancer and senescenceYuzhu Zhang, Jiaxi Tang, Can Jiang, et al.
Medcomm|March 11, 2025
Clinical Utility of <sup>18</sup>Fluorine-Fibroblast Activation Protein Inhibitor-04 Positron Emission Tomography/Computed Tomography in the Evaluation of Pancreatic Ductal Adenocarcinoma: Comparison With <sup>18</sup>Fluorine-Fluorodeoxyglucose Positron Emission Tomography/Computed TomographyLili Lin, Guangfa Wang, Yafei Zhang, et al.
Medcomm|March 11, 2025
RNA Modification in MetabolismYadi Liu, Zhongyan Sun, Dingkun Gui, et al.
Medcomm|December 6, 2024
Single-cell transcriptomic analysis of glioblastoma reveals pericytes contributing to the blood-brain-tumor barrier and tumor progressionYuzhe Li, Changwu Wu, Xinmiao Long, et al.
Medcomm|December 2, 2024
Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targetsShen'er Qian, Yao Long, Guolin Tan, et al.
Medcomm|November 29, 2024
Extracellular vesicles in cancers: mechanisms, biomarkers, and therapeutic strategiesYuxi Ma, Xiaohui Zhang, Cuiwei Liu, et al.
Medcomm|November 29, 2024
Ocular immune-related diseases: molecular mechanisms and therapyYakun Wang, Shangze Gao, Fan Cao, et al.
Medcomm|December 16, 2024
Deubiquitinases as novel therapeutic targets for diseasesYali Xian, Jing Ye, Yu Tang, et al.
Medcomm|December 13, 2024
Inhibition of Selenoprotein I promotes ferroptosis and reverses resistance to platinum chemotherapy by impairing Akt phosphorylation in ovarian cancerJing Li, Mimi Chen, Dingwen Huang, et al.
Medcomm|November 21, 2024
Ferroptosis: mechanisms and therapeutic targetsQian Zhou, Yu Meng, Jiayuan Le, et al.
Pageof 153

Showing results (411-420 of 1,530) with videos related to

Sort By:
Pageof 153
Medcomm|March 6, 2025
Metabolic reprogramming in cancer and senescenceYuzhu Zhang, Jiaxi Tang, Can Jiang, et al.
Medcomm|March 11, 2025
Clinical Utility of <sup>18</sup>Fluorine-Fibroblast Activation Protein Inhibitor-04 Positron Emission Tomography/Computed Tomography in the Evaluation of Pancreatic Ductal Adenocarcinoma: Comparison With <sup>18</sup>Fluorine-Fluorodeoxyglucose Positron Emission Tomography/Computed TomographyLili Lin, Guangfa Wang, Yafei Zhang, et al.
Medcomm|March 11, 2025
RNA Modification in MetabolismYadi Liu, Zhongyan Sun, Dingkun Gui, et al.
Medcomm|December 6, 2024
Single-cell transcriptomic analysis of glioblastoma reveals pericytes contributing to the blood-brain-tumor barrier and tumor progressionYuzhe Li, Changwu Wu, Xinmiao Long, et al.
Medcomm|December 2, 2024
Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targetsShen'er Qian, Yao Long, Guolin Tan, et al.
Medcomm|November 29, 2024
Extracellular vesicles in cancers: mechanisms, biomarkers, and therapeutic strategiesYuxi Ma, Xiaohui Zhang, Cuiwei Liu, et al.
Medcomm|November 29, 2024
Ocular immune-related diseases: molecular mechanisms and therapyYakun Wang, Shangze Gao, Fan Cao, et al.
Medcomm|December 16, 2024
Deubiquitinases as novel therapeutic targets for diseasesYali Xian, Jing Ye, Yu Tang, et al.
Medcomm|December 13, 2024
Inhibition of Selenoprotein I promotes ferroptosis and reverses resistance to platinum chemotherapy by impairing Akt phosphorylation in ovarian cancerJing Li, Mimi Chen, Dingwen Huang, et al.
Medcomm|November 21, 2024
Ferroptosis: mechanisms and therapeutic targetsQian Zhou, Yu Meng, Jiayuan Le, et al.
Pageof 153